Telix Pharmaceuticals (TLX) Assets Average (2024 - 2026)
Telix Pharmaceuticals (TLX) posted quarterly Assets Average of $628.0 million for Q4 2024.
Powered by 
Analysis
Telix Pharmaceuticals (TLX) Assets Average (2024 - 2026) Analysis & Trends
Telix Pharmaceuticals (TLX) has reported Assets Average for 1 consecutive years, with $628.0 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Assets Average changed N/A year-over-year to $628.0 million; the TTM figure through Dec 2024 stood at $628.0 million (changed N/A YoY), while the FY2024 annual figure was $628.0 million, changed N/A from the prior year.
- Assets Average was little changed at $628.0 million in Q4 2024 per TLX's latest filing.
- Across five years, Assets Average topped out at $628.0 million in Q4 2024 and bottomed at $628.0 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn | 11.22 Bn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | 3.29 Bn |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | 8.86 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Telix Pharmaceuticals | 4.03 Bn | 3.74 Bn | - | 1.26 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.26 Bn |
| Dec 31, 2025 | 1.08 Bn |
| Dec 31, 2024 | 627.98 Mn |